Other
Drug Facts
Distributed by:
JOHNSON & JOHNSON
CONSUMER INC.
Skillman, NJ 08558
The following Structured Product Label (SPL) was submitted to the FDA by Kenvue Brands Llc for the product Neutrogena Stubborn Body Acne Treatment (NDC 69968-0758). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient, purpose, use, warnings, when using this product, otc - keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Distributed by:
JOHNSON & JOHNSON
CONSUMER INC.
Skillman, NJ 08558
Salicylic Acid 2%
Acne treatment
For external use only. Flammable: Keep away from fire or flame.
■ Avoid contact with eyes. If contact occurs, immediately flush with water.
■ Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
■ Clean the skin thoroughly before applying this product
■ Cover the entire affected area with a thin layer one to three times daily
■ Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
■ If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Water, Alcohol Denat., Butylene Glycol, PPG-5-Ceteth-20, C12-15 Alkyl Lactate, Sodium citrate, Cocamidopropyl PG-Dimonium Chloride Phosphate, Benzalkonium Chloride, Cetyl Lactate, Sodium Benzotriazolyl Butylphenol Sulfonate, Disodium EDTA, Sodium Hydroxide, Glycolic Acid
800-582-4048; Outside US, dial collect 215-273-8755 or visit www.neutrogena.com
* Please review the disclaimer below.